Arbor Biotechnologies Appoints Deanna M. Petersen as Chief Business Officer
CAMBRIDGE, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) — Arbor Biotechnologies®, a biotechnology company discovering and…
News
Arbor Biotechnologies Appoints Deanna M. Petersen as Chief Business Officer
CAMBRIDGE, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) — Arbor Biotechnologies®, a biotechnology company discovering and…
Tonix Pharmaceuticals Completes Clinical Phase of PREVAIL Proof-of-Concept Study of TNX-102 SL for the Treatment of Fibromyalgia-Type Long COVID
Topline Results Expected Third Quarter 2023 Long COVID Afflicts Approximately 19% of Patients Following COVID-191,…
Tonix Pharmaceuticals Completes Clinical Phase of PREVAIL Proof-of-Concept Study of TNX-102 SL for the Treatment of Fibromyalgia-Type Long COVID
Topline Results Expected Third Quarter 2023 Long COVID Afflicts Approximately 19% of Patients Following COVID-191,…
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction
Ikena receives approximately $43 million in net cash at closing New capital will further accelerate…
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction
Ikena receives approximately $43 million in net cash at closing New capital will further accelerate…
Praxis Precision Medicines Announces Positive Results of EEG Analysis of PRAX-628 Phase 1 Study
Composite qEEG measure showed change from placebo after first dose of 5 mg Effect in…
Praxis Precision Medicines Announces Positive Results of EEG Analysis of PRAX-628 Phase 1 Study
Composite qEEG measure showed change from placebo after first dose of 5 mg Effect in…
Tango Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Highlights
– First patient dosed in phase 1/2 trial of TNG462, a next-generation PRMT5 inhibitor for…
Tango Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Highlights
– First patient dosed in phase 1/2 trial of TNG462, a next-generation PRMT5 inhibitor for…
Gritstone bio Partners with Friends of Cancer Research (Friends) on the ctDNA to Monitor Treatment Response (ctMoniTR) Project
EMERYVILLE, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage…
Gritstone bio Partners with Friends of Cancer Research (Friends) on the ctDNA to Monitor Treatment Response (ctMoniTR) Project
EMERYVILLE, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage…
Krystal Biotech Announces Second Quarter 2023 Financial Results and Operational Highlights
• VYJUVEK™ approved in the U.S. as the first and only topical redosable gene therapy for…
Krystal Biotech Announces Second Quarter 2023 Financial Results and Operational Highlights
• VYJUVEK™ approved in the U.S. as the first and only topical redosable gene therapy for…
Pharvaris Reports Second Quarter 2023 Financial Results and Provides Business Update
Enrollment completed in Phase 2 CHAPTER-1 prophylactic study; top-line data anticipated by YE2023 Clinical hold…
CENTOGENE to Participate in Upcoming Conferences in August
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Aug. 07, 2023 (GLOBE NEWSWIRE) — Centogene N.V….
Flexsteel Industries, Inc. to Announce Fourth Quarter 2023 Results on August 21
Conference call and webcast to be held on Tuesday, August 22, 2023 DUBUQUE, Iowa–(BUSINESS WIRE)–Flexsteel…
Annexon Highlights Recent Pipeline and Business Progress and Reports Second Quarter 2023 Financial Results
ARCHER Trial Results Presented at ASRS Further Demonstrate Preservation of Visual Function in Patients with…
WSO2 Launches Startup Program to Accelerate Journeys to Success for App Entrepreneurs
Early-stage startups are invited to join and gain access to a range of tools, services,…
Sonim Enters Next Chapter of Accelerated Growth and Expansion with New Category of Data Devices
Company strengthens expansion strategy with addition of new hires for connected solutions category, marketing, and…